[1]
Abdel-Razeq, H. and Mansour, R. 2026. Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants. World Journal of Oncology. 17, 1 (Jan. 2026), 14–24. DOI:https://doi.org/10.14740/wjon2692.